BrightPath Biotherapeutics Co., Ltd.
4594.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥1,252,592 | ¥900,980 | ¥810,470 | ¥1,260,968 |
| Short-Term Investments | ¥0 | ¥0 | ¥0 | ¥0 |
| Receivables | ¥0 | ¥36 | ¥64,679 | ¥36 |
| Inventory | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Curr. Assets | ¥32,978 | ¥24,784 | ¥13,127 | ¥139,927 |
| Total Curr. Assets | ¥1,647,258 | ¥1,161,460 | ¥1,071,315 | ¥1,400,931 |
| Property Plant & Equip (Net) | ¥0 | ¥0 | ¥0 | ¥0 |
| Goodwill | ¥0 | ¥0 | ¥0 | ¥0 |
| Intangibles | ¥0 | ¥0 | ¥0 | ¥0 |
| Long-Term Investments | ¥0 | ¥0 | ¥0 | ¥0 |
| Tax Assets | ¥0 | ¥0 | ¥0 | ¥0 |
| Other NC Assets | ¥50,634 | ¥49,297 | ¥49,297 | ¥49,297 |
| Total NC Assets | ¥50,634 | ¥49,297 | ¥49,297 | ¥49,297 |
| Other Assets | ¥1 | ¥0 | ¥0 | ¥0 |
| Total Assets | ¥1,697,893 | ¥1,210,757 | ¥1,120,612 | ¥1,450,228 |
| Liabilities | – | – | – | – |
| Payables | ¥9 | ¥9 | ¥35 | ¥24 |
| Short-Term Debt | ¥0 | ¥0 | ¥25,000 | ¥162,500 |
| Tax Payable | ¥16,291 | ¥0 | ¥0 | ¥0 |
| Deferred Revenue | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Curr. Liab. | ¥88,257 | ¥86,176 | ¥89,558 | ¥78,827 |
| Total Curr. Liab. | ¥104,557 | ¥93,417 | ¥131,661 | ¥251,291 |
| LT Debt | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Rev, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Tax Liab, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Other NC Liab. | ¥66,880 | ¥65,633 | ¥63,962 | ¥67,063 |
| Total NC Liab. | ¥66,880 | ¥65,633 | ¥63,962 | ¥67,063 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liabilities | ¥171,437 | ¥159,050 | ¥195,623 | ¥318,354 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥0 |
| Common Stock | ¥1,732,629 | ¥1,384,533 | ¥1,199,869 | ¥1,135,145 |
| Retained Earnings | -¥4,267,601 | -¥4,046,734 | -¥3,804,864 | -¥3,468,800 |
| AOCI | ¥20,268 | ¥20,841 | ¥21,580 | ¥21,849 |
| Other Equity | ¥0 | ¥1 | ¥1 | -¥1 |
| Total Equity | ¥1,526,456 | ¥1,051,706 | ¥924,987 | ¥1,131,873 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liab. & Tot. Equity | ¥1,697,893 | ¥1,210,756 | ¥1,120,612 | ¥1,450,227 |
| Net Debt | -¥1,252,592 | -¥900,980 | -¥785,470 | -¥1,098,468 |